Corrigendum to “Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels” Corrigendum to: Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels (Journal of Thrombosis and Haemostasis, (2018), 16, 1, (104-115), (S153878362203639X), 10.1111/jth.13881)

  • Marcus Lehmann
  • , Katrina Ashworth
  • , Marilyn Manco-Johnson
  • , Jorge Di Paola
  • , Keith B. Neeves
  • , Christopher J. Ng

Research output: Contribution to journalComment/debate

Abstract

In Lehman et al1, there an error in the nomenclature regarding platelet-dependent VWF activity assays. The use of the term “VWF:Gp1bR” in the manuscript implies the use of the “HemosIL von Willebrand factor ristocetin cofactor assay”. However, to our best knowledge the actual assay was the HemosIL VWF Activity assay, and thus the correct term for platelet-dependent VWF activity in the manuscript should be “VWF:Ab” instead of “VWF:Gp1bR.”. The authors regret this error.

Original languageEnglish
Pages (from-to)786
Number of pages1
JournalJournal of Thrombosis and Haemostasis
Volume24
Issue number2
DOIs
StatePublished - Feb 2026

Fingerprint

Dive into the research topics of 'Corrigendum to “Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels” Corrigendum to: Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels (Journal of Thrombosis and Haemostasis, (2018), 16, 1, (104-115), (S153878362203639X), 10.1111/jth.13881)'. Together they form a unique fingerprint.

Cite this